Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gynecologic 2Lymphoid 1

Conditions

Uterine Cervical Neoplasms 1Lymphoma, Follicular 1Endometrial Neoplasms 1Disease 1

Interventions

pembrolizumab 3copanlisib 2aflibercept 2X-Rays 2Specimen Handling 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1temsirolimus 1selinexor 1sapanisertib 1relatlimab 1pertuzumab 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1ipatasertib 1erdafitinib 1epacadostat 1enzalutamide 1entinostat 1defactinib 1dabrafenib 1ciforadenant 1capivasertib 1binimetinib 1atezolizumab 1adavosertib 1Trastuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Diffusion Magnetic Resonance Imaging × Lymphoid × Clear all
NCT01836484 2020-02-13

MAPPING

Barts & The London NHS Trust

Completed
162 enrolled
GynecologicLymphoid

Uterine Cervical Neoplasms, Disease, Lymphoma, Follicular, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡